Treatment of HER2-positive metastatic breast cancer with lapatinib and capecitabine in the lapatinib expanded access programme, including efficacy in brain metastases – the UK experience

✍ Scribed by Sutherland, S; Ashley, S; Miles, D; Chan, S; Wardley, A; Davidson, N; Bhatti, R; Shehata, M; Nouras, H; Camburn, T

• Book ID: 110000385
• Publisher: Nature Publishing Group
• Year: 2010
• Tongue: English
• Weight: 450 KB
• Volume: 102
• Category: Article
• ISSN: 0007-0920
• DOI: 10.1038/sj.bjc.6605586